NIBSC - Parvovirus B19 meeting

Enter a search term

Home Page > Spotlight > Standardisation of Genome Amplification Techniques > Blood virology > Past meetings > Parvovirus B19 meeting

Parvovirus B19 meeting

Return to previous page|

March 2007 Presentations

Speaker	Presentation
Session 1: Welcome address and aims of the meeting
Dr K. Brown, HPA, London	View Presentation
Dr. Jean-Marc Spieser, EDQM, Strasbourg	View Presentation
Dr. Mei-ying Yu, CBER FDA	View Presentation
Session 2: Prevalence and clinical properties of parvovirus B19
Kati Hokynar, Haartman Institute, Helsinki	View Presentation
Professor S. Modrow, University of Regensburg	View Presentation
Dr. D. Candotti, Cambridge	View Presentation
Session 3: Plasma products; presence of B19 genotypes and inactivation
A.M. Eis-Hübinger, University of Bonn	View Presentation
Dr. Mei-ying Yu, CBER FDA	View Presentation
Dr. M. Nübling, PEI, Langen	View Presentation
Professor J.P. Allain, University of Cambridge	View Presentation
Session 4: Experience with commercial and in-house assays
Dr. S. Baylis, NIBSC	View Presentation
Dr. T. Cuijpers, IPFA/Sanquin, Amsterdam	View Presentation
Dr. M. José, Grifols, Barcelona	View Presentation
Dr. T. Gierman, Talecris, Raleigh, USA	View Presentation
Session 5: Provision of plasmid clones to OMCL network and manufacturers
Dr J. Fryer/Dr S. Baylis, NIBSC	View Presentation
Session 8: Availability of B19 viraemic plasma for reference panel development Genotype 2
Dr. M. Gessner , Baxter, Vienna	View Presentation
Dr S. Baylis, NIBSC, London	View Presentation
Dr. M. Koppelman, Sanquin, Amsterdam	View Presentation
Dr. M. José, Grifols, Barcelona	View Presentation
Genotype 3
Dr. D. Candotti, Cambridge	View Presentation
Possible additional sources of genotype 2 and 3 plasma
Dr K. Brown, HPA, London	View Presentation
Dr. D. York, Molecular Diagnostic Services Pty Ltd, South Africa	View Presentation

Parvovirus B19 meeting

March 2007 Presentations

Speaker

Presentation